Edema describes swelling associated with injury, inflammation, or fluid overload. It happens when fluid from the small blood vessels leaks into tissues. Edema can affect a small or large area or even ...

What Is Bone Marrow Edema? Bone marrow edema (BME) is when fluid builds up in your bone marrow. Your doctor may call it bone marrow lesions. The most common locations for it are your: Hip Knee ...

Macular edema is swelling in the eye's retina that causes blurry vision but can progress to more serious vision loss. The most common condition associated with macular edema is diabetic retinopathy, ...

Abnormalities of the vitreoretinal interface may contribute to important retinal pathologies such as diabetic retinopathy, diabetic macular edema and age-related macular degeneration. The ...

Diabetic macular edema (DME) is a complication of diabetes that occurs when fluid builds up in the macula, the part of the retina responsible for central vision. This can lead to blurred or double ...

Learn how small bowel obstruction develops, warning signs to watch for, and proven methods to prevent serious complications.

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 ...

Patients will give a history of minor trauma such as contusion, insect bite, frostbite, chronic leg ulcer, or a surgical incision, and present with severe pain and edema to their health care provider.

Diabetic macular edema (DME) is a leading cause of vision loss in people with diabetes. It occurs when high blood sugar levels damage small blood vessels in the retina, the light-sensitive tissue ...

This paper reviews the pathophysiology of the relationship between “cortical venous drainage ... Due to the lack of a smooth muscle cell layer, the venous system is more prone to tissue edema and ...

Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks achieved non-inferior visual acuity outcomes compared to Eylea in patients ...